Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications
Primary Purpose
Cardiac Disease
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PET-MRI
Sponsored by

About this trial
This is an interventional diagnostic trial for Cardiac Disease focused on measuring Positron Emission Tomography-Magnetic Resonance Imaging, Cardiac Disease
Eligibility Criteria
Inclusion Criteria:
- Subjects with ischemic and non-ischemic cardiac disease referred for cardiac PET for viability imaging.
Exclusion Criteria:
- Contraindications for MRI, including cardiac pacemaker, claustrophobia, retained metallic foreign body, cochlear implant, Aneurysm clip in the brain, pregnancy and eGFR less than 45%.
Sites / Locations
- UCSF University of California in San Francisco
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Cardiac patients receiving PET/MR
Arm Description
PET-MRI with intravenous Gadolinium and FDG. The entire study will take approximately one hour.
Outcomes
Primary Outcome Measures
Number of Quality PET and PET/MR Images With Regional Myocardial Uptake of 18F-Fluorodeoxyglucose (FDG) in Participants Without Overt Diagnosis of Ischemic Coronary Artery Disease.
Visual analysis of collected image pairs. Evaluated by experienced imaging providers as yes or no.
Secondary Outcome Measures
Full Information
NCT ID
NCT02062008
First Posted
February 7, 2014
Last Updated
May 20, 2021
Sponsor
University of California, San Francisco
1. Study Identification
Unique Protocol Identification Number
NCT02062008
Brief Title
Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications
Official Title
Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Terminated
Why Stopped
Lack of funding to continue.
Study Start Date
December 2016 (Actual)
Primary Completion Date
February 10, 2018 (Actual)
Study Completion Date
February 10, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to understand how simultaneous PET/MR acquisition can provide novel qualitative and quantitative biomarkers to guide clinical intervention and predict prognosis of patients with cardiovascular disease.
Detailed Description
To compare regional myocardial uptake of FDG on images obtained on a standard PET camera with the new PET/MR camera, in patients with coronary artery disease.
To compare viability maps obtained with cardiac MR images and FDG-PET for delineation of myocardial infarct core and border zone, in patients with coronary artery disease.
To correlate MRI myocardial strain with relative myocardial FDG uptake in patients with a previous myocardial infarction.
To interrogate if simultaneous acquisition of cardiac PET and viability cardiac MR differ from acquisitions obtained independently, with special focus on attenuation correction methods
To combined MRI scar map with FDG-PET uptake in patients with cardiac sarcoidosis and myocarditis.
To correlate morphologic characteristics of atherosclerotic disease in the thoracic and abdominal aorta with FDG uptake and ferumoxytol enhancement, as a marker of inflammation.
To evaluate cardiac strain and myocardial scar burden in obese patients with and without diabetes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Disease
Keywords
Positron Emission Tomography-Magnetic Resonance Imaging, Cardiac Disease
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
2 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cardiac patients receiving PET/MR
Arm Type
Other
Arm Description
PET-MRI with intravenous Gadolinium and FDG. The entire study will take approximately one hour.
Intervention Type
Device
Intervention Name(s)
PET-MRI
Intervention Description
PET-MRI with intravenous Gadolinium and FDG. The entire study will take approximately one hour.
Primary Outcome Measure Information:
Title
Number of Quality PET and PET/MR Images With Regional Myocardial Uptake of 18F-Fluorodeoxyglucose (FDG) in Participants Without Overt Diagnosis of Ischemic Coronary Artery Disease.
Description
Visual analysis of collected image pairs. Evaluated by experienced imaging providers as yes or no.
Time Frame
2 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects with ischemic and non-ischemic cardiac disease referred for cardiac PET for viability imaging.
Exclusion Criteria:
Contraindications for MRI, including cardiac pacemaker, claustrophobia, retained metallic foreign body, cochlear implant, Aneurysm clip in the brain, pregnancy and eGFR less than 45%.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karen G Ordovas, MD,MAS
Organizational Affiliation
Assistent Professor
Official's Role
Principal Investigator
Facility Information:
Facility Name
UCSF University of California in San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94107
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications
We'll reach out to this number within 24 hrs